MPA_Gyn_5

Category

MPA_Gyn_5




Useful info

MPA_Gyn_5 Brand names, MPA_Gyn_5 Analogs

MPA_Gyn_5 Brand Names Mixture

  • Lunelle (Medroxyprogesterone + Estradiol)

    • MPA_Gyn_5 Chemical_Formula

    C22H32O3

    MPA_Gyn_5 RX_link

    http://www.rxlist.com/cgi/generic/medrox.htm

    MPA_Gyn_5 fda sheet

    MPA_Gyn_5 FDA

    MPA_Gyn_5 msds (material safety sheet)

    MPA_Gyn_5 Synthesis Reference

    P. Ruggieri, C. Ferrari, U.S. Pat. 3,043,832 (1962)

    MPA_Gyn_5 Molecular Weight

    344.488 g/mol

    MPA_Gyn_5 Melting Point

    220 - 223.5 oC

    MPA_Gyn_5 H2O Solubility

    22.2mg/L

    MPA_Gyn_5 State

    Solid

    MPA_Gyn_5 LogP

    3.606

    MPA_Gyn_5 Dosage Forms

    Tablets; Depo injection

    MPA_Gyn_5 Indication

    Used as a contraceptive and to treat amenorrhea, abnormal uterine bleeding, endometriosis, endometrial and renal cell carcinomas, and pulmonary disorders such as chronic obstructive pulmonary disease (COPD), Pickwickian syndrome, and other hypercapnic pulmonary conditions.

    MPA_Gyn_5 Pharmacology

    Medroxyprogesterone is a synthetic progestin more potent than progesterone.

    MPA_Gyn_5 Absorption

    Rapidly absorbed from GI tract

    MPA_Gyn_5 Toxicity

    Side effects include loss of bone mineral density, BMD changes in adult women, bleeding irregularities, cancer risks, and thromboembolic disorders.

    MPA_Gyn_5 Patient Information

    MPA_Gyn_5 Organisms Affected

    Humans and other mammals